Orion Biotech Opportunities - Warrants (15/04/2025) Total Liabilities

The latest total liabilities for ORIAW is $8.3M as of December 2022. That compares with $15M in the prior-year period — down 44.9% year over year. Investors often review this figure alongside Orion Biotech Opportunities - Warrants (15/04/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ORIAW's total liabilities moved from $15M to $8.3M — a 44.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orion Biotech Opportunities - Warrants (15/04/2025)'s operating scale or balance-sheet position.

A total liabilities figure of $8.3M for ORIAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ORIAW's total liabilities ($8.3M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.